Status:
UNKNOWN
Protective Effect in Cardiac Surgery Patients
Lead Sponsor:
Shanghai Zhongshan Hospital
Conditions:
Cardiac Surgery
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
The purpose of the study was to verify the protective effect of inhibiting systemic inflammatory response in patients undergoing cardiac surgery.
Eligibility Criteria
Inclusion
- subject needs to have valve surgery
- subject needs to have coronary artery bypass grafting surgery
- subject needs to have artificial blood vessel replacement surgery
- ASA(American Society of Anesthesiologists) score II\~III
- NYHA(New York Heart Association) II\~III
Exclusion
- LVEF(left ventricular ejection fraction) \<40% measured by echocardiogram
- history of myocardial infarction within 1 month
- history of serious pulmonary infection or endocarditis within 3 months
- history of important surgery within 6 months
Key Trial Info
Start Date :
August 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2021
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT04028024
Start Date
August 1 2019
End Date
June 1 2021
Last Update
July 22 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.